• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于欧盟遗忘权立法以获取癌症幸存者金融服务的研究

Towards an EU legislation on the right to be forgotten to access to financial services for cancer survivors.

机构信息

European Cancer Patient Coalition (ECPC), Belgium.

ECPC Scientific Committee, Belgium.

出版信息

Eur J Cancer. 2022 Feb;162:133-137. doi: 10.1016/j.ejca.2021.12.001. Epub 2022 Jan 3.

DOI:10.1016/j.ejca.2021.12.001
PMID:34990965
Abstract

INTRODUCTION

Financial discrimination may affect an increasing number of cancer survivors in Europe as a consequence of the improvement of cancer management. According to the latest projections, Europe counts around 20 million cancer survivors. In the few years, the issue raised the attention of the European policymakers.

OBJECTIVES

The goal of this study is to promote political and legal solutions taking into consideration the need to stop discrimination against cancer survivors. The article also aims to implement legal principles on patients' rights and social values at the national and European levels, emphasising EU competence on the matter.

METHODS

The article reviews the current legal aspects concerning the right to be forgotten (RTBF) for cancer survivors in Europe, and it analyses the EU competency for its implementation.

RESULTS

The legislative initiatives in force in France, Belgium, Luxembourg, the Netherlands, and Portugal provide concrete examples of an effective solution for former patients that should be extended throughout the EU. Under these circumstances, the European Legislator could lead on multiple initiatives to implement at the European level the RTBF, as our research has demonstrated the EU competency for these matters.

CONCLUSION

A Pan-European solution based on the implementation of the RTBF is feasible within current treaties and seems the best approach to tackle the issue. The EU Action would provide a common and harmonised regulatory framework among the Member States to avoid discrimination and ensure equality among EU citizens being cured of cancer.

摘要

简介

随着癌症管理水平的提高,欧洲越来越多的癌症幸存者可能会面临经济歧视。根据最新预测,欧洲有 2000 万癌症幸存者。在过去几年中,这一问题引起了欧洲政策制定者的关注。

目的

本研究旨在提出政治和法律解决方案,以停止对癌症幸存者的歧视。本文还旨在在国家和欧洲层面实施有关患者权利和社会价值观的法律原则,强调欧盟对此事的管辖权。

方法

本文回顾了欧洲现行有关癌症幸存者被遗忘权(RTBF)的法律方面,并分析了实施该权利的欧盟管辖权。

结果

法国、比利时、卢森堡、荷兰和葡萄牙现行的立法举措为前患者提供了具体的有效解决方案范例,应在整个欧盟范围内推广。在这种情况下,欧洲立法者可以在多个层面上采取主动行动,在欧洲层面实施 RTBF,因为我们的研究已经证明了欧盟对此类事项的管辖权。

结论

在现有条约的基础上,基于实施被遗忘权的泛欧解决方案是可行的,这似乎是解决这一问题的最佳途径。欧盟的行动将在成员国之间提供一个共同和协调的监管框架,以避免歧视,并确保已治愈癌症的欧盟公民之间的平等。

相似文献

1
Towards an EU legislation on the right to be forgotten to access to financial services for cancer survivors.关于欧盟遗忘权立法以获取癌症幸存者金融服务的研究
Eur J Cancer. 2022 Feb;162:133-137. doi: 10.1016/j.ejca.2021.12.001. Epub 2022 Jan 3.
2
Protecting cancer survivors from financial discrimination throughout the EU: A cross-European perspective.保护欧盟癌症幸存者免受经济歧视:跨欧视角。
Eur J Cancer. 2024 Sep;209:114238. doi: 10.1016/j.ejca.2024.114238. Epub 2024 Jul 20.
3
Challenges and solutions to embed cancer survivorship research and innovation within the EU Cancer Mission.将癌症生存研究和创新嵌入欧盟癌症防治计划所面临的挑战和解决方案。
Mol Oncol. 2021 Jul;15(7):1750-1758. doi: 10.1002/1878-0261.13022. Epub 2021 Jun 15.
4
A research roadmap for complementary and alternative medicine - what we need to know by 2020.补充和替代医学研究路线图——到2020年我们需要了解的内容。
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
5
Social diversity and access to healthcare in Europe: how does European Union's legislation prevent from discrimination in healthcare?欧洲的社会多样性与医疗保健服务可及性:欧盟立法如何防止医疗保健领域的歧视?
BMC Public Health. 2020 Sep 14;20(1):1399. doi: 10.1186/s12889-020-09494-8.
6
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
7
[A proposal for reforming psychologists' training in France and in the European Union].[关于法国及欧盟心理学家培训改革的一项提议]
Encephale. 2009 Feb;35(1):18-24. doi: 10.1016/j.encep.2007.11.008. Epub 2008 Apr 2.
8
Health care policy and cancer survivorship.卫生保健政策与癌症生存
Cancer. 2013 Jun 1;119 Suppl 11:2187-99. doi: 10.1002/cncr.28066.
9
Ending financial discrimination for cancer survivors: embedding the Right to be Forgotten in legislation across Europe.终结对癌症幸存者的经济歧视:将被遗忘权纳入欧洲各国立法
Lancet Oncol. 2024 Sep;25(9):1123-1126. doi: 10.1016/S1470-2045(24)00312-7. Epub 2024 Aug 13.
10
Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?欧盟临床试验法规能否支持创新产业更快地为患者带来新药?
Pharmaceut Med. 2013 Apr;27(2):75-82. doi: 10.1007/s40290-013-0012-8.

引用本文的文献

1
Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype.青少年及年轻成人乳腺癌患者按年龄、分期和受体亚型划分的诊断后长达10年的5年条件相对生存率。
J Natl Cancer Cent. 2025 Mar 31;5(3):297-305. doi: 10.1016/j.jncc.2025.01.005. eCollection 2025 Jun.
2
Should Patients Be Able To Delete their Electronic Health Records??患者应该能够删除自己的电子健康记录吗?
J Med Syst. 2025 May 10;49(1):61. doi: 10.1007/s10916-025-02194-z.
3
Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030.
将被治愈的癌症患者以及意大利2018年至2030年的完全患病率预测。
ESMO Open. 2024 Jul;9(7):103635. doi: 10.1016/j.esmoop.2024.103635. Epub 2024 Jul 23.
4
Achieving a Brighter Future: A Career-Focused Mentoring Program Designed for Adolescents and Young Adults with Cancer.实现更光明的未来:一项为患有癌症的青少年和年轻人设计的以职业为重点的指导计划。
Contin Educ. 2024 Jun 17;5(1):90-99. doi: 10.5334/cie.106. eCollection 2024.